• Adverse Events Decreased With Proton Chemoradiotherapy drugs
    January 06, 2020
    Proton chemoradiotherapy is associated with a significantly lower risk for 90-day adverse events and a decrease in performance status during treatment compared with photon therapy, according to a study published online December in JAMA Oncology.
PharmaSources Customer Service